These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16406508)

  • 21. Effects of tandospirone, a 5-HT1A receptor-related anxiolytic, on the pressor response elicited by stimulation of the posterior hypothalamus in cats.
    Tsuji R; Ohno Y; Hirose A; Shimizu H; Tanaka H; Nakamura M
    Arch Int Pharmacodyn Ther; 1991; 311():131-43. PubMed ID: 1686389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions.
    Matsubara K; Shimizu K; Suno M; Ogawa K; Awaya T; Yamada T; Noda T; Satomi M; Ohtaki K; Chiba K; Tasaki Y; Shiono H
    Brain Res; 2006 Sep; 1112(1):126-33. PubMed ID: 16884702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different effects of anxiolytic agents, diazepam and 5-HT(1A) agonist tandospirone, on hippocampal long-term potentiation in vivo.
    Mori K; Togashi H; Kojima T; Matsumoto M; Ohashi S; Ueno K; Yoshioka M
    Pharmacol Biochem Behav; 2001; 69(3-4):367-72. PubMed ID: 11509193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT1A agonists disrupt memory of fear conditioning in mice.
    Quartermain D; Clemente J; Shemer A
    Biol Psychiatry; 1993 Feb; 33(4):247-54. PubMed ID: 8471677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tandospirone in three behavioral tests for anxiolytics.
    Pollard GT; Nanry KP; Howard JL
    Eur J Pharmacol; 1992 Oct; 221(2-3):297-305. PubMed ID: 1358655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of tandospirone on second messenger systems and neurotransmitter release in the rat brain.
    Tanaka H; Tatsuno T; Shimizu H; Hirose A; Kumasaka Y; Nakamura M
    Gen Pharmacol; 1995 Dec; 26(8):1765-72. PubMed ID: 8745167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
    Elkina Y; Palus S; Tschirner A; Hartmann K; von Haehling S; Doehner W; Mayer U; Coats AJ; Beadle J; Anker SD; Springer J
    Int J Cardiol; 2013 Dec; 170(2):160-6. PubMed ID: 24207070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic treatment with tandospirone, a 5-HT(1A) receptor partial agonist, suppresses footshock stress-induced lactate production in the prefrontal cortex of rats.
    Uehara T; Matsuoka T; Itoh H; Sumiyoshi T
    Pharmacol Biochem Behav; 2013 Nov; 113():1-6. PubMed ID: 24125783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--II. Effects of acute administration of 1-PP and long-term administration of tandospirone on noradrenergic neurotransmission.
    Blier P; Curet O; Chaput Y; de Montigny C
    Neuropharmacology; 1991 Jul; 30(7):691-701. PubMed ID: 1681447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effects of tandospirone on ataxia of a patient with Machado-Joseph disease.
    Takei A; Honma S; Kawashima A; Yabe I; Fukazawa T; Hamada K; Hamada T; Tashiro K
    Psychiatry Clin Neurosci; 2002 Apr; 56(2):181-5. PubMed ID: 11952922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noradrenergic alpha-2 agonists have anxiolytic-like actions on stress-related behavior and mesoprefrontal dopamine biochemistry.
    Morrow BA; George TP; Roth RH
    Brain Res; 2004 Nov; 1027(1-2):173-8. PubMed ID: 15494168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tandospirone suppresses impulsive action by possible blockade of the 5-HT1A receptor.
    Ohmura Y; Kumamoto H; Tsutsui-Kimura I; Minami M; Izumi T; Yoshida T; Yoshioka M
    J Pharmacol Sci; 2013; 122(2):84-92. PubMed ID: 23707971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
    J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult rats exposed to early-life social isolation exhibit increased anxiety and conditioned fear behavior, and altered hormonal stress responses.
    Lukkes JL; Mokin MV; Scholl JL; Forster GL
    Horm Behav; 2009 Jan; 55(1):248-56. PubMed ID: 19027017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in amygdala neural activity that occur with the extinction of context-dependent conditioned fear stress.
    Izumi T; Inoue T; Kato A; Kitaichi Y; Nakagawa S; Koyama T
    Pharmacol Biochem Behav; 2008 Sep; 90(3):297-304. PubMed ID: 18410955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites.
    Hamik A; Oksenberg D; Fischette C; Peroutka SJ
    Biol Psychiatry; 1990 Jul; 28(2):99-109. PubMed ID: 1974152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor.
    Kakui N; Yokoyama F; Yamauchi M; Kitamura K; Imanishi T; Inoue T; Koyama T
    Pharmacol Biochem Behav; 2009 May; 92(3):393-8. PubMed ID: 19167420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subchronic lithium treatment increases the anxiolytic-like effect of mirtazapine on the expression of contextual conditioned fear.
    An Y; Inoue T; Kitaichi Y; Nakagawa S; Wang C; Chen C; Song N; Kusumi I
    Eur J Pharmacol; 2015 Jan; 747():13-7. PubMed ID: 25438255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of anxiolytics, diazepam and tandospirone, on immobilization stress-induced hyperglycemia in mice.
    Sugimoto Y; Yamada J; Noma T
    Life Sci; 1998; 63(14):1221-6. PubMed ID: 9771911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
    Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
    Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.